Gagnon Robert E.
Opus Genetics, Inc. · Chief Financial Officer
Gagnon Robert E. is listed in public filings as officer: Chief Financial Officer. This Gagnon Robert E. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Opus Genetics, Inc. (IRD), Verastem, Inc. (VSTM), Harvard Bioscience, Inc. (HBIO), Bone Biologics Corporation (BBLGW), and Bone Biologics Corporation (BBLG). Investors use Gagnon Robert E.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $41k7.8k shares | SellApr 23, 2026 | $5.18 | -- |